Showing 46-50 of 166 news & articles:
Meet Your 40 Under 40 Winner – Joseph Zabinski, PhD, MEM Managing Director of AI & Personalized Medicine, OM1

Healthcare Innovation September 19, 2023 Read the full article >> Congratulations to 40 Under 40 Winner: Joseph Zabinski, PhD, MEM, Managing Director of AI & Personalized Medicine, OM1 Get To Know Joseph: Age (as of December 31, 2023): 35 Hometown: Cortlandt Manor, NY Alma Mater: Boston College (BS), Dartmouth (MEM), UNC (PhD) Number of Years of Experience in Healthcare: 8[…]

A new era of integrated evidence generation: Deep dive into OM1 case study spotlight from the DIA Real-World Evidence Conference 2023

November 1, 2023 The Evidence Base Read the full article >> In a recent presentation at the DIA Real-Word Evidence (RWE) Conference (October 16–17, 2023, Baltimore, MD, USA), Sonja Wustrack, Managing Director of Integrated Evidence Generation at OM1 (MA, USA), discussed strategies for optimizing evidence generation in clinical research. She described the OM1 approach to[…]

OM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand RWE

HIT Consultant October 3, 2023 Read the full article >> What You Should Know: – OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. – Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient[…]

Stefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology Network

Dermatology Times October 3, 2023 Read the full article >> OM1, a real-world data and AI technology company, recently announced the continued expansion of its Dermatology Network to now include hidradenitis suppurativa (HS), adding approximately 26,000 new patient records to its database. The addition of the HS database will help find innovative solutions and improve health outcomes[…]

1 8 9 10 11 12 34